{"id":"W4376862903","doi":"10.1158/1078-0432.c.6637744","title":"Data from Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Adjuvant; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Biomarker; Melanoma; Cancer; Cancer research; Immunotherapy; Chemistry; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00430375,0.0006841492,0.001395114,0.0004893958,0.0003016378,0.000828149,0.0007324399,0.0007952879,0.001718453],"category_scores_gemma":[0.002996536,0.0002920036,0.002257028,0.0005751892,0.0003225875,0.0007538128,0.0003207533,0.001399121,0.0005146661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008094404,"about_ca_system_score_gemma":0.0007648869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001748525,"about_ca_topic_score_gemma":0.003128738,"domain_scores_codex":[0.9986899,0.0006434359,0.0001174921,0.0001590204,0.0002990898,0.0000910831],"domain_scores_gemma":[0.9952246,0.001534065,0.001469449,0.0006226682,0.0004175593,0.0007315472],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6614081,0.005323252,0.1411281,0.002621656,0.01392712,0.0006663012,0.00033642,0.006921472,0.03346092,0.0002694853,0.02001922,0.113918],"study_design_scores_gemma":[0.09393723,0.1313387,0.7195391,0.0003899953,0.01445253,0.001243578,0.0001307424,0.003722578,0.01299908,0.0003500122,0.02173653,0.0001599],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.974402,0.008753786,0.000542148,0.0005526551,0.0001104199,0.0003229883,0.01212163,0.00008242296,0.003111987],"genre_scores_gemma":[0.9795179,0.001651102,0.0003819114,0.0006737733,0.0001338536,0.0002091314,0.01596766,0.00003216397,0.001432477],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.00430375,"threshold_uncertainty_score":0.02276069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1262407783185109,"score_gpt":0.3357840804169919,"score_spread":0.2095433020984811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}